$27.13
In chiusura: Oct 13 EDT
$27.13
0.000.00%
Pre-mercato: 4:00 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Celldex Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 5
Stima EPS
$-0.890
Stima dei ricavi trimestrali
$1.32M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$5.79M
Analizza lo storico degli utili di Celldex Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
CLDX | Celldex Therapeutics | -$0.64 | -$0.89 | — | — | $3.19M | $1.32M | — | — | 11/05/2025 | |
CLDX | Celldex Therapeutics | -$0.54 | -$0.85 | -$0.85 | 0.00% | $2.50M | $1.35M | $730.00K | -45.82% | 08/07/2025 | |
CLDX | Celldex Therapeutics | -$0.56 | -$0.74 | -$0.81 | -9.46% | $156.00K | $1.08M | $695.00K | -35.65% | 05/08/2025 | |
CLDX | Celldex Therapeutics | -$0.83 | -$0.73 | -$0.71 | 2.74% | $4.13M | $1.31M | $1.18M | -10.31% | 02/27/2025 | |
CLDX | Celldex Therapeutics | -$0.81 | -$0.68 | -$0.64 | 5.88% | $1.52M | $920.00K | $3.19M | 246.85% | 11/06/2024 | |
CLDX | Celldex Therapeutics | -$0.65 | -$0.60 | -$0.54 | 10.00% | $268.00K | $820.43K | $2.50M | 204.47% | 08/08/2024 | |
CLDX | Celldex Therapeutics | -$0.62 | -$0.69 | -$0.56 | 18.84% | $967.00K | $920.00K | $156.00K | -83.04% | 05/06/2024 | |
CLDX | Celldex Therapeutics | -$0.56 | -$0.74 | -$0.83 | -12.16% | $1.61M | $840.00K | $4.13M | 391.90% | 02/26/2024 | |
CLDX | Celldex Therapeutics | -$0.57 | -$0.68 | -$0.81 | -19.12% | $407.00K | $580.00K | $1.52M | 161.55% | 11/02/2023 | |
CLDX | Celldex Therapeutics | -$0.77 | -$0.67 | -$0.65 | 2.99% | $163.00K | $530.00K | $268.00K | -49.43% | 08/08/2023 | |
CLDX | Celldex Therapeutics | -$0.49 | -$0.63 | -$0.62 | 1.59% | $174.00K | $410.00K | $967.00K | 135.85% | 05/04/2023 | |
CLDX | Celldex Therapeutics | -$0.43 | -$0.59 | -$0.56 | 5.08% | $333.00K | $260.00K | $1.61M | 520.38% | 02/28/2023 | |
CLDX | Celldex Therapeutics | -$0.37 | -$0.58 | -$0.57 | 1.72% | $153.00K | — | $407.00K | — | 11/09/2022 | |
CLDX | Celldex Therapeutics | -$0.34 | -$0.51 | -$0.77 | -50.98% | $3.48M | $400.00K | $163.00K | -59.25% | 08/08/2022 | |
CLDX | Celldex Therapeutics | -$0.42 | -$0.45 | -$0.49 | -8.89% | $685.00K | $560.00K | $174.00K | -68.93% | 05/05/2022 | |
CLDX | Celldex Therapeutics | -$0.55 | -$0.42 | -$0.43 | -2.38% | $3.79M | — | $333.00K | — | 02/28/2022 | |
CLDX | Celldex Therapeutics | -$0.36 | -$0.37 | -$0.37 | 0.00% | $668.00K | $1.12M | $153.00K | -86.34% | 11/09/2021 | |
CLDX | Celldex Therapeutics | -$0.50 | — | -$0.34 | — | $236.00K | $685.00K | $3.48M | 408.03% | 08/05/2021 | |
CLDX | Celldex Therapeutics | -$0.73 | -$0.38 | -$0.42 | -10.53% | $2.73M | $685.00K | $685.00K | 0.00% | 05/06/2021 | |
CLDX | Celldex Therapeutics | -$0.64 | — | -$0.55 | — | $887.00K | — | $3.79M | — | 03/29/2021 | |
CLDX | Celldex Therapeutics | -$0.75 | — | -$0.36 | — | $546.00K | — | $668.00K | — | 11/05/2020 |
Celldex Therapeutics (CLDX) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $-0.85 | $-0.85 | 0.00 % |
| Q1 | 2025-05-08 | $-0.81 | $-0.74 | -9.46 % |
| Q4 | 2025-02-27 | $-0.71 | $-0.73 | 2.74 % |
| Q3 | 2024-11-06 | $-0.64 | $-0.68 | 5.88 % |
Celldex Therapeutics (CLDX) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $730.00K | $1.35M | -45.8 % |
| Q1 | 2025-05-08 | $695.00K | $1.08M | -35.6 % |
| Q4 | 2025-02-27 | $1.18M | $1.31M | -10.3 % |
| Q3 | 2024-11-06 | $3.19M | $920.00K | 246.9 % |
FAQ
Quando Celldex Therapeutics (NASDAQ:CLDX) riporterà gli utili?
Si prevede che Celldex Therapeutics (CLDX) fornisca risultati il novembre 5, 2025. Gli ultimi risultati sono stati pubblicati il agosto 7, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Celldex Therapeutics (NASDAQ:CLDX)?
L'EPS effettivo era $-0.85, che centrato la stima di $-0.85.
Quali sono state le entrate di Celldex Therapeutics (NASDAQ:CLDX)?
Le entrate effettive sono state $730K, che mancato la stima di $1.3M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.